Search results
15 hours ago · The medication or drug is commonly used to treat alcohol use disorder, and results in immediate hangover-like symptoms upon consumption of alcohol, this effect is widely known as disulfiram effect. Metronidazole. Metronidazole is an antibacterial agent that kills bacteria by damaging cellular DNA and hence cellular function.
- Moderate (10–15%)
- /ˈɛθənɒl/
- Moderate
5 hours ago · For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. ... Children’s Hospital led an effort to persuade the Food and ...
15 hours ago · Recently, in a triple-negative breast cancer in vivo studies, Hyundai Bioscience demonstrated that the combination therapy group with oral niclosamide-based anticancer agent and docetaxel, the widely-used chemotherapeutic drug, showed 67% higher anticancer effects compared to the docetaxel-alone treatment group.
15 hours ago · Microbix also applies its biological expertise and infrastructure to develop other proprietary products and technologies, most notably Kinlytic ® urokinase, a biologic thrombolytic drug used to treat blood clots, and reagents or media to support molecular diagnostic testing (e.g., its Dx™™ for patient-sample collection).
15 hours ago · Ondine has a pipeline of investigational products, based on its proprietary photodisinfection technology, in various stages of development. Ondine's nasal photodisinfection system has a CE mark in Europe and the UK and is approved in Canada and several other countries under the name Steriwave®.
9 hours ago · Ondine has a pipeline of investigational products, based on its proprietary photodisinfection technology, in various stages of development. Ondine's nasal photodisinfection system has a CE mark in Europe and the UK and is approved in Canada and several other countries under the name Steriwave®.
15 hours ago · Non-regulatory announcement. ONDINE BIOMEDICAL INC. ("Ondine Biomedical", "Ondine", or the "Company") New study confirms nose is key source of infection. Findings include 86% of surgical site infections ("SSIs") caused by bacteria from the patients' own nose, skin, or gut and nearly 60% of infections are resistant to antibiotics
